Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...

Pipeline Therapies, Drugs Sales, and Regional Outlook The report provides a detailed analysis of the current apraxia marketed ...